These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 38541800)

  • 21. Antineoplastic Drug-Induced Cardiotoxicity: A Redox Perspective.
    Varricchi G; Ameri P; Cadeddu C; Ghigo A; Madonna R; Marone G; Mercurio V; Monte I; Novo G; Parrella P; Pirozzi F; Pecoraro A; Spallarossa P; Zito C; Mercuro G; Pagliaro P; Tocchetti CG
    Front Physiol; 2018; 9():167. PubMed ID: 29563880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrophysiologic Toxicity of Chemoradiation.
    Armanious MA; Mishra S; Fradley MG
    Curr Oncol Rep; 2018 Apr; 20(6):45. PubMed ID: 29644475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer Therapies and Vascular Toxicities.
    Meilhac A; Cautela J; Thuny F
    Curr Treat Options Oncol; 2022 Mar; 23(3):333-347. PubMed ID: 35244888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiotoxicity of cancer chemotherapy: implications for children.
    Simbre VC; Duffy SA; Dadlani GH; Miller TL; Lipshultz SE
    Paediatr Drugs; 2005; 7(3):187-202. PubMed ID: 15977964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beyond Anthracyclines: Preemptive Management of Cardiovascular Toxicity in the Era of Targeted Agents for Hematologic Malignancies.
    Sethi TK; Basdag B; Bhatia N; Moslehi J; Reddy NM
    Curr Hematol Malig Rep; 2017 Jun; 12(3):257-267. PubMed ID: 28233150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of QT prolongation induced by anti-cancer drugs: Target therapy and old agents. Different algorithms for different drugs.
    Coppola C; Rienzo A; Piscopo G; Barbieri A; Arra C; Maurea N
    Cancer Treat Rev; 2018 Feb; 63():135-143. PubMed ID: 29304463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. From Molecular Mechanisms to Clinical Management of Antineoplastic Drug-Induced Cardiovascular Toxicity: A Translational Overview.
    Tocchetti CG; Cadeddu C; Di Lisi D; Femminò S; Madonna R; Mele D; Monte I; Novo G; Penna C; Pepe A; Spallarossa P; Varricchi G; Zito C; Pagliaro P; Mercuro G
    Antioxid Redox Signal; 2019 Jun; 30(18):2110-2153. PubMed ID: 28398124
    [No Abstract]   [Full Text] [Related]  

  • 28. Managing chemotherapy-related cardiotoxicity in survivors of childhood cancers.
    Lipshultz SE; Diamond MB; Franco VI; Aggarwal S; Leger K; Santos MV; Sallan SE; Chow EJ
    Paediatr Drugs; 2014 Oct; 16(5):373-89. PubMed ID: 25134924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective surveillance and management of cardiac toxicity and health in breast cancer survivors.
    Schmitz KH; Prosnitz RG; Schwartz AL; Carver JR
    Cancer; 2012 Apr; 118(8 Suppl):2270-6. PubMed ID: 22488701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac toxicity from systemic cancer therapy: a comprehensive review.
    Curigliano G; Mayer EL; Burstein HJ; Winer EP; Goldhirsch A
    Prog Cardiovasc Dis; 2010; 53(2):94-104. PubMed ID: 20728696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiotoxicity of Biological Therapies in Cancer Patients: An In-depth Review.
    Madanat L; Gupta R; Weber P; Kumar N; Chandra R; Ahaneku H; Bansal Y; Anderson J; Bilolikar A; Jaiyesimi I
    Curr Cardiol Rev; 2023; 19(3):e310522205428. PubMed ID: 35642110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxidative stress in anticancer therapies-related cardiac dysfunction.
    Attanasio U; Pirozzi F; Poto R; Cuomo A; Carannante A; Russo M; Ghigo A; Hirsch E; Tocchetti CG; Varricchi G; Mercurio V
    Free Radic Biol Med; 2021 Jun; 169():410-415. PubMed ID: 33930514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardio-oncology: management of cardiovascular toxicity.
    Markman TM; Markman M
    F1000Res; 2019; 8():. PubMed ID: 30755794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetics of cancer therapy-associated cardiotoxicity.
    Kim Y; Seidman JG; Seidman CE
    J Mol Cell Cardiol; 2022 Jun; 167():85-91. PubMed ID: 35358500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New progress in elucidating the relationship between cancer therapy and cardiovascular toxicity.
    Wu C; Lin D; Ma F; Jiang F; Wang Y
    Biosci Trends; 2021 Sep; 15(4):211-218. PubMed ID: 34305102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toxicity of chloroquine and hydroxychloroquine following therapeutic use or overdose.
    Doyno C; Sobieraj DM; Baker WL
    Clin Toxicol (Phila); 2021 Jan; 59(1):12-23. PubMed ID: 32960100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemotherapy and Cardiotoxicity in Hematologic Malignancies.
    Stellitano A; Fedele R; Barilla S; Iaria A; Rao CM; Martino M
    Curr Cancer Drug Targets; 2017; 17(4):311-324. PubMed ID: 27903214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac toxicities of anticancer treatments: chemotherapy, targeted therapy and immunotherapy.
    Zarifa A; Albittar A; Kim PY; Hassan S; Palaskas N; Iliescu C; Durand JB; Lopez-Mattei J
    Curr Opin Cardiol; 2019 Jul; 34(4):441-450. PubMed ID: 31082852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular toxicity of biologic agents for cancer therapy.
    Bhave M; Akhter N; Rosen ST
    Oncology (Williston Park); 2014 Jun; 28(6):482-90. PubMed ID: 25134321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanobiotechnology-based strategies in alleviation of chemotherapy-mediated cardiotoxicity.
    Luo X
    Environ Res; 2023 Dec; 238(Pt 2):116989. PubMed ID: 37633635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.